drugset / Trial / NCT06254183

Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy(LSG)

NCT06254183

Phase 4 Completed 90 enrolled Tanta University
RandomizedParallel-groupSingle-blindPrevention

Summary

Assessment of the effect of gabapentin as an analgesic replacement on the Kidney function following Laparoscopic sleeve gastrectomy for Morbid Obese Patients by measuring two biomarkers: NGAL (Neutrophil gelatinase-associated lipocalin)and DKK3 (Dickkopf-3)

Timeline

Start
2024-12-01
Primary completion
2025-05-01
Completion
2025-11-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg Oral